Molecular Diagnostics Market by Application (Infectious Disease, Genetic Testing, Oncology), Technology (PCR, INAAT & NGS), End User (Hospital/Reference Laboratories) - Global Forecast to 2023
- July, 2017
- Domain: Healthcare - Diagnostics
- Get Free 10% Customization in this Report
Overview of the Global Molecular Diagnostics Market Research
Infoholic’s market research report predicts that the global molecular diagnostics market will grow at a CAGR of 8.7% during the forecast period. The market for molecular diagnostics is driven by increasing prevalence of infectious and other lifestyle diseases, increasing demand for non-invasive biomarker-based tests, growing adoption of point-of-care testing, and high growth of the market in emerging countries. Increasing number of mergers & acquisitions and growing significance of companion diagnostics are providing opportunities for the market growth. Low awareness about standardization, stringent regulatory approval process, and lack of skilled labors are hampering the market growth.
According to the molecular diagnostics industry analysis, North America accounted for the largest share of the global molecular diagnostics market in 2017. The reason for the market’s growth in the Americas is the increasing incidences of disease and organ transplantation in the US along with increasing funding by government and private players and increased adoption of personalized medicine in clinical practices are some of the factors driving the molecular diagnostics market growth. The Asia Pacific region is expected to witness the fastest growth rate due to the large patient pool, increasing awareness, and rising healthcare expenditure.
Molecular Diagnostics Market Research competitive analysis and key vendors
Molecular diagnostics are performed mainly to examine the existence of the disease in blood, tissue, or even in bones. The importance of nucleic acids and other cellular biomarkers in defining the vital cellular process has facilitated medical advancements in the diagnosis of various diseases. Early diagnosis of the disease is one of the key advantages of this technology. The capacity of molecular diagnostics to systematize molecular reactions for the enhancement of the clinical diagnosis has put healthcare in the front line. The increasing importance of molecular diagnostic tests has resulted in the launch of new tests and also increased acquisition, strategic partnership, and funding to develop new tests and technologies. For instance, in April 2018, NanoString Technologies, Inc. launched a Breast Cancer 360 (BC 360) research panel. In July 2017, MDxHealth SA announced the commercial launch of its AssureMDx for bladder cancer test in the US as a laboratory developed test. Illumina recently started a new company, named GRAIL, for liquid biopsy. It invested $100 million and raised another $900 million through public funding to develop new non-invasive tests for cancer diagnosis.
Some of the Key Vendors in the Molecular Diagnostics Market Research are:
- Hoffmann-La Roche
- Abbott Diagnostics
- Siemens Healthineers
Molecular Diagnostics Market Research by Application type
- Blood Testing
- Infectious Disease
- Genetic Testing
- Tissue Typing
In 2017, the infectious disease application occupied the largest share due to large number of patients suffering from hospital-associated infection, sexually transmitted infection (STI), hepatitis, respiratory infection, pathogen ID detection, and others is fostering the market growth, but oncology is expected to grow at the highest growth rate during the forecast period due to increasing incidence of cancer globally.
Molecular Diagnostics Market Research By Technology
- DNA Sequencing
- Other MDX Technology
In 2017, the PCR segment occupied the largest share. PCR is a gold standard technique for DNA amplification and is the primary technique conducted prior to any molecular diagnostic examination Next-generation sequencing and microarray are expected to grow at the fastest rate during the forecast period.
Molecular Diagnostics Market Research By End-Users
- Reference Laboratories
In 2017, the hospitals occupied the largest share and is expected to continue the same trend during the forecast period.
Molecular Diagnostics Market Research Benefits
The report provides detailed information about the usage and adoption of molecular diagnostics market in various applications and regions. With that, key stakeholders can find out the major trends, drivers, investments, vertical player’s initiatives, government initiatives toward the product adoption in the upcoming years, along with the details of commercial products available in the market. Moreover, the report provides details about the major challenges that are going to have an impact on market growth. Additionally, the report gives complete details about the business opportunities to key stakeholders to expand their business and capture revenues in the specific verticals. The report will help companies interested or established in this market to analyze the various aspects of this domain before investing or expanding their business in the molecular diagnostics market.
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Related Markets
3.3.2 Clinical Chemistry
4 Market Outlook
4.1 Market Definition – Infoholic Research
4.2 Market Segmentation
4.3 Porter 5(Five) Forces
5 Market Characteristics
5.1 Milestones in Molecular Diagnostics
5.2 Basic steps of molecular diagnostics
5.3 Market Dynamics
22.214.171.124 Increasing prevalence of Infectious diseases
126.96.36.199 Growing adoption of POC testing
188.8.131.52 Increasing demand for biomarker-based tests
184.108.40.206 High growth of market in emerging countries
220.127.116.11 Growing significance of companion diagnostics
18.104.22.168 Increased number of Merger and Acquisition
22.214.171.124 Increased adoption of DNA probe-based diagnostics
126.96.36.199 Stringent regulatory approvals
188.8.131.52 Lack of skilled labor
5.3.4 DRO – Impact Analysis
5.3.5 Key Stakeholders
6 Market Segmentation by Technology: Market Size and Analysis
6.2 Polymerase Chain Reaction (PCR)
6.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
6.6 DNA Sequencing
6.7 Other MDX technology
7 Market Segmentation by Application: Market Size and Analysis
7.3 Blood Testing
7.4 Infectious Diseases
7.5 Genetic Testing
7.6 Tissue Typing
8 End-user: Market Size and Analysis
8.3 Reference Laboratories
9 Regions: Market Size and Analysis
9.2 North America
9.2.1 US 40
9.3.1 UK 41
9.5 Rest of the World
10 Competitive Landscape
11 Vendor Profiles
11.1 F.Hoffmann-La Roche Ltd
11.1.2 Business Unit
11.1.3 Geographic Presence
11.1.4 Business Focus
11.1.5 SWOT Analysis
11.1.6 Business Strategy
11.2 Abbott Laboratories
11.2.2 Business Unit
11.2.3 Geographic Presence
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategy
11.3 Siemens Healthineers Inc.
11.3.2 Geographic Presence
11.3.3 Business Focus
11.3.4 SWOT Analysis
11.3.5 Business Strategy
11.4 Danaher Corporation.
11.4.2 Business Unit
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategy
11.5 Hologic Inc.
11.5.2 Business Unit
11.5.3 Geographic Presence
11.5.4 Business Focus
11.5.5 SWOT Analysis
11.5.6 Business Strategy
12 Companies to Watch For
12.1 Becton Dickinson and Company
12.2 Bio-Rad Laboratories, Inc.
12.3 QIAGEN NV
12.4 bioMerieux S.A.
12.5 ThermoFisher Scientific.
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
Market related information is congregated from both primary and secondary sources.
Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.